BSECompany Update1d ago · 17 Nov 2026, 06:40 pm
Submission of Newspaper Publication Copies of the Unaudited Financial Results of the Company for the quarter and half year ended 30th September, 2026
Virgo Polymer India Ltd · 531282
✦ AI SummaryResults
Virgo Polymer India Ltd has submitted the newspaper publication copies of its unaudited financial results for the quarter and half year ended 30th September 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Virgo Polymer India Ltd - 531282 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Attachments (1)
📄pdf
Download →
3709a1bb-5094-4cd8-8fad-ce04c77a98b4.pdf
View document text
' IRG O
Virgo Polymers (India) Ltd.
A1A MMDA Indi Complex, MM Nagar,
POLYME RS Chengalpet. Dist. - 603209. India.
(INDIA) LTD E-mail: Info@VirgoPolymer.Com
Datdg{ 78489030 48825
vember; 2026
The Compliance Department,
BSE Limited,
25%Floor, Phiroze Jeejeebhoy Towers,
Dalal Street, Fort
Mumbai - 400001,
Scrip Code: 531282; ISIN: INE464H01015
fS ou rb j te hc et : q u- aN re tw es rp aa np de hr a P lu f b yl ei ac ra t ei no dn e o df 3th 0e t U Sn ea pu td ei mt be ed r F 2in 0a 2n 6c :i al Results of the Company
Dear Sir/Ma’am,
Name of the Newspaper [ Edition
Trinity Mirror ‘ English
Makkal Kural [ Tamil
A copy of the newspaper clippings are attached herewith,
This is for information and records. Kindly take note of the same.
Thanking You,
Yours Faithfully,
For Virgo Polymers India Limited
Vivek Ramsisaria
Managing Director
DIN: 01942187
GSTIN - 33AAACV8490Q1ZL
CIN No - L25200TN1985PLC011622
virgopolymer.com
i IRROR
CHENNAI - 14-NOVEMBER-2026
How do—you live 50 years with diabetes?
World Diabetes Day
Dr. Mohan has the answer
f oni cg eh .t en Wi i lfw laa bn ey “ 1t . Te hp hse e” a o eqp f ul r ee to s, ot m i gh oa ie n vsa d er o ci cn o utg pmo er tt hh as ee t t FDo i hn oa e ub neN dt Meo aas iv . d oe r nm a ,Sb sp e e icr ni Da ail s1 at s4 i b o, e ce s it aeD tr s iC. o e nn R tM e wro ise teh haa a rr tn c hs d h e S wo iT, t i hvh io n dw g i a d bi 0 ed t, é t s 6h 0 ae , n yd de o ve n si tt? a y6 i5 n g ye fa rr es e
f h meo aao r Tntd h, ys o sm eg1 oy wol odo e r yv ree ys e? e, s a rW am s ri y el d uok n ii dt d | e n na he sf a tyf avse ne?c d t a H ble lom f ety w .? H 2 Sp eei vdon i epd a rlu b aej e l a t w e oF sh fo ou f t n o hrd h e a a m mt vi oeo wr n ee, T r i etvr hee ad 9c n 0o w g 5i oi 0t rs h e y oed lt a d y r ep1 s re0 o r s “df ae i im sda c c iro pk lm ta ihp b nel el i ”e c . aa nt Hsi w eo Bn e us rt s aim w dDi arg . s th ht e M sio mms eh po da lu an en ld @D D Ahr o i. l s dM i fo n oh g r a Ain t l a cs l .lu Atm o m g fee et sd th e tu r hp : a tt h re ei fr l ea cp tsp r ao va ec rah g a es bt lh oe o A d B sC ug am ra n ot vr ea r, t w hi rt eh e
a tD hni es d b e et it ne ds n es oc f d so a cf ai fr uf c lc , l l on B fg iu f_ et .c on id At i ct ri oo s sn t s, E Dia Tac b hh e e t er se ac e wGi aov rle ddd s e nth we J eu rbDr i e. l eeV p . r M eeM sd eo a nh l ta en d w e ci x an t mn r ee e r m fs e r om md ei d a sn ts' ct u_ ar ds y,s u hc aTe bihc tee sid r t ht s eh u yr c o c ku e eg s ph s t & ‘ B tm h o ein s t hf eh o as r r. t b ,l ko iod d nepr ye ss asu nr de . e yK ee se .pi ng it in a healthy range protects
t al nh i de v _ e dc sou twnt air yy t, e h d di hm ea aba len tty he y s , p fe aoo crp il id ve e e c ah da ev anse d b V Ay i n o jh at a nh n ae , , C m ve a in n ct a er g e i' cns hg a ic d rih mra e ai c nr t om ra D rn .D ,D Rr aR. n M j. iV. t A Bealthy, balanced diete _n wt aly s 4 C Kei es p if no gr ic t h io nl e cs ht eer co kl , p rp oa tr et ci tc su l ta hr el y h eL arD tL , a nt dh e b l“ ob oda d v” e ssc eh lo sl .e sterol.
Fi ind te yp e yn ed ae rn st sin tt ro o nt ghe ,i r a n80 d5 ha on nd o re905 d, MU en nn di hk ir .i shn pa rn o, g raa mn md e D dr i. recA ts orh is oh f o rp ep ao lir st eu n ti ht ey r p1 oo t enl te aa lr .n , Reg cr oo gnw i_ sa in nd g Spa hr ot r tto ef r mt !he i fr x .e veryday life, not & D s for discipline, the habit that makes the other three possible.
rf Ao e hr R c c e e ait c i d ve en dt o fl y s, Wp oe rci ls a do l m De ir aec boo egf tn e i st it oh n D.e a ym ct s wh a ihe i ti d hf H tci g hn u id c ylu s d |tj r pea dn ia s bd eF ed to r eu se n ans dd s da , yt e i o so D u ern n.. r g v eMI p en een vod eph h rli i yes ct a hh s en ae pc li io tr r hu a .r t s ia g oc neh ssi e wv t he h im e le m en ts t m, o a np auh gre s i u ne g.a dd t thhe eed ii, rr ‘ s r theS p egm eN ia co ml i hn el a o. le nh oa A rb eo c ei qft c eu s soi, rpt m d hhp e ie ar n ns da te gc t t(i hh oc ra e eob D ed i r .td t sa ho M i iol nny gs be t sarc i nd ie ,s t n t v si mh s ae i li t lr s _ d ao dlc e jt t u o sr tts mh. ee ni tr sR e d 1og ocu tl o ma r er s d icc aml ti a in k oi e nc dl io gn bg, e tea sc t ai nve d cli hfe a. s iT ngh e b iy go au mn bg i tiT oI nD .
Common. over time. These small changes can zo hand in hand.
New drugs, smart devices signal major 5"y walked evry day Dr ket fhels umbers i rnge o “This World Diabetes Day. their
Mohan stressed that this didn't 9ec: message is clear: diabeles ro
advances in diabetes care in 2026 m 0-e ma in n uin tt ee ns we a lkw ,o rko du ot ns e. A fa it3 h0 f- u lt lo y V Thl ei kt Gi om le d, é nw e Jl u bi iv le eed medallisis con Ss mi as lt le nc cy h: o ices made every day
every day, was enough. living proof that a_diabetes for decades add up o a long and
3 They kept in touch with diagnosis can be the strt of o healiby life.
inity mirror
Online Team:
obsM ea rr vk ei dn g toW do ayr ld ( ND oi va eb me bte es r D 1a )y ,. Regtred oOff oce V rAI o gR oG -1O p, P mMO O eL rY iM e|E oW R o bsS ,l IND ssI A c omML |gI M C oI ha T n 5.E 0 5D G 0 45 812 3 T0
this special compilation highlights
Some of the significant advances in Extract ot he statements of Unauited Financial Results for the quarter ended 30th September 2026
digbetes treament and management et
unveiled in 2026, including new Onswik, a once-weekly basal S BVET AR
medicines, wearableglucose insulin injection
monitaring_systems and_next- The technology can provide early
zencration insulin delivery devices, indications of rising ketone levels, - S T | o T T
These innovations are simed ot Ielping identfy the isk of diabetic nesrea| e S oo
improving patient convenience, Abbott’s Libre Duo Ketoacidosis, a_potentally life-
treatment outcomes and quality of hreatening compheation.
life_for millions of people living levels over seven days, potentially Insulin delivery technology has e ot b o TR ) ) =
with diabets. reducing the burden of daily basal also advanced,
One of the notable developments insulin injections for adulis with Tandem Diabetes Care has
i the US approval of Onswik, 2 Type 2 disbetes. received_regulatory clearancefor
nce-weekly basal insulin injection Another developmen is Abbo's a tubeless version of its Mobi
developed by pharmaceutical Libre Duo, a Wearable sensor automated insulin delivery system,
Eli Lilly The teament is designed o monitor both lucose offering greater fexibility and
ed 1o provide steady insulin and ketone levels. continuously
These developments
reflecta growing. shift
towards _personalised
mn o O W NG, e o TG o 4 05 1 0P 5 G o m ino sn ui lt io nr i dn eg l ia vn ed automated 2 The Compy hd R aodoptT ecod o io SA cO cv u mo in S tiads ,rd sS 15 o A (Sv ) o )o b tL he Oto t or, 20 B 1S70 o th1e e5se 5 o ie ol eo t o vo . be5s en ee ok o
- copmamagpeote oo Smariphone conncctiviy 1 o CRIEC/13001 e 10 ot 205 s b
UNAUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS and wearable technology
FOR THE QUARTEANRD HALF YEAR ENDED SEPTEMBER 30, 2026 are increasingly helping
In compnce wits Rogulsion 33 of the SEBI (Using Obigators snd Dscsure patients and_healthcare fi
R emane Bsaho, 73 500 b o o TRt 1 ABS OIS professionals rack glucose
el s o G, Eopoes e EOEL. ot e ks on levels and make informed
Mo 135175 e Approie 1. it Stvinons = treament decisions
Cancoldated iancal st for th v and i e onded] (] these
Seprombor 02028 st ; innovations are subject
T Con as va, sed d bo y r Wg i RI Cb IS &L i An et sd o iS es LLF o St l y (i sm o0 o 1o individual medical m SUGAL EARTHEN?PACES VENTURES LIMITED
G i s o v Conny et o ] S carten spaces. SptHous, 1 i, a1, og so, sk, O 6000
RS S U oo com. e o s " BTRACOTF UNAUDITED CONSOLIDATED AND STANDALOE FIVANCIAL RESULTS FOR THE
ks oo ek e Oy e in' different_countris. ‘QUARTER AND HALF YEAR ENDED 30th SEPTEMBER, 2026 (huinatng
ForPosL Enerprses Lmvea | | Doctors advise patients
sa- || 1o consult healtheare
Plce: Chemal aashish Kumar K ain [ | 1510 fea
[Showing first 8,000 characters — download PDF for full document]